Eftrenonacog Alfa
ATC B02BD04 · 5 markets · 22 records
AU 7 records · 7 strengths
- 4,000 IUunknownALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe
- 3,000 IUunknownALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe
- 2,000 IUunknownALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe
- 1,000 IUunknownALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe
- 500 IUunknownALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe
- 250 IUunknownALPROLIX eftrenonacog alfa (rhu) 500 IU powder for injection vial and diluent pre-filled syringe
Records without a stated strength · 1 ALPROLIX
GB 5 records · 1 strengths
Records without a stated strength · 1 Alprolix 1,000unit powder and solvent for solution for injection vials、Alprolix 2,000unit powder and solvent for solution for injection vials、Alprolix 250unit powder and solvent for solution for injection vials、Alprolix 3,000unit powder and solvent for solution for injection vials、Alprolix 500unit powder and solvent for solution for injection vials
ES 5 records · 5 strengths
HK 4 records · 1 strengths
Records without a stated strength · 1 ALPROLIX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1000IU
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ALPROLIX
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.